Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941–1953 (2019).

Article  CAS  PubMed  Google Scholar 

Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim. 6, 92 (2020).

Article  PubMed  Google Scholar 

HHS.gov. Smoking Cessation: A Report of the Surgeon General — Key Findings https://www.hhs.gov/surgeongeneral/reports-and-publications/tobacco/2020-cessation-sgr-factsheet-key-findings/index.html#:~:Text=2020%20Surgeon%20General’s%20Report%20Findings,a%20decade%20to%20life%20expectancy (2020).

Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).

Article  PubMed  Google Scholar 

Chaturvedi, A. K. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29, 4294–4301 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Powell, S. F., Vu, L., Spanos, W. C. & Pyeon, D. The key differences between human papillomavirus-positive and -negative head and neck cancers: biological and clinical implications. Cancers 13, 5206 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferris, R. L. et al. Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: efficacy and safety in CheckMate 141 by prior cetuximab use. Clin. Cancer Res. 25, 5221–5230 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonner, J. A. et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354, 567–578 (2006).

Article  CAS  PubMed  Google Scholar 

Cramer, J. D., Burtness, B. & Ferris, R. L. Immunotherapy for head and neck cancer: recent advances and future directions. Oral. Oncol. 99, 104460 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, L. et al. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer. Sci. Rep. 10, 6395 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mito, I. et al. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Sci. Rep. 11, 16134 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mandal, R. et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight 1, e89829 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Jiang, A.-M. et al. Tumor mutation burden, immune cell infiltration, and construction of immune-related genes prognostic model in head and neck cancer. Int. J. Med. Sci. 18, 226–238 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, X. et al. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis. Mol. Immunol. 96, 28–36 (2018).

Article  CAS  PubMed  Google Scholar 

Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556–560 (2020).

Article  CAS  PubMed  Google Scholar 

Ruffin, A. T. et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat. Commun. 12, 3349 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wood, O. et al. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. Oncotarget 7, 56781–56797 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Wuerdemann, N. et al. LAG-3, TIM-3 and VISTA expression on tumor-infiltrating lymphocytes in oropharyngeal squamous cell carcinoma-potential biomarkers for targeted therapy concepts. Int. J. Mol. Sci. 22, 379 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Lechner, A. et al. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Oncotarget 8, 44418–44433 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Liu, Z. et al. Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients. Clin. Cancer Res. 24, 4529–4538 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, J.-F. et al. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer. J. Exp. Clin. Cancer Res. 37, 44 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Hwang, B., Lee, J. H. & Bang, D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp. Mol. Med. 50, 1–14 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuksin, M. et al. Applications of single-cell and bulk RNA sequencing in onco-immunology. Eur. J. Cancer 149, 193–210 (2021).

Article  CAS  PubMed  Google Scholar 

Chaudhry, F. et al. Single-cell RNA sequencing of the cardiovascular system: new looks for old diseases. Front. Cardiovasc. Med. 6, 173 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, X. & Wang, C.-Y. From bulk, single-cell to spatial RNA sequencing. Int. J. Oral. Sci. 13, 36 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Kürten, C. H. L. et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat. Commun. 12, 7338 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Cillo, A. R. et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity 52, 183–199.e9 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611–1624.e24 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, Q. et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma. Ann. Transl. Med. 9, 1017 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nordfors, C. et al. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur. J. Cancer 49, 2522–2530 (2013).

Article  CAS  PubMed  Google Scholar 

Wuerdemann, N. et al. PD-L1 expression and a high tumor infiltrate of CD8+ lymphocytes predict outcome in patients with oropharyngeal squamous cells carcinoma. Int. J. Mol. Sci. 21, 5228 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, Z. et al. PD-L1 in combination with CD8+ TIL and HIF-1α are promising prognosis predictors of head and neck squamous cell carcinoma. Cancer Manag. Res. 12, 13233–13239 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao, Y. et al. CD103+ T and dendritic cells indicate a favorable prognosis in oral cancer. J. Dent. Res. 98, 1480–1487 (2019).

Article  CAS  PubMed  Google Scholar 

McKinney, E. F. & Smith, K. G. T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion. Curr. Opin. Immunol. 43, 74–80 (2016).

Article  CAS  PubMed  Google Scholar 

Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).

Article 

留言 (0)

沒有登入
gif